Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$477.00 USD

477.00
2,610,261

-6.36 (-1.32%)

Updated Aug 5, 2025 04:00 PM ET

Pre-Market: $478.94 +1.94 (0.41%) 9:04 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks News

Indrajit Bandyopadhyay headshot

ISRG da Vinci 5 Gets European Nod: Will it Boost the Stock's Prospect?

ISRG's da Vinci 5 wins CE mark, unlocking Europe's surgical robotics market as U.S. adoption shows strong early traction.

Zacks Equity Research

Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark

ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet.

Zacks Equity Research

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Indrajit Bandyopadhyay headshot

Can ISRG Maintain Robotics Edge Amid Rising Rivalry & Budget Strain?

ISRG posted strong Q1 growth, but rising rivals and tighter hospital budgets test its robotics dominance and pricing power.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $534.38, denoting a +2.44% move from the preceding trading day.

Zacks Equity Research

Wall Street Analysts See Intuitive Surgical (ISRG) as a Buy: Should You Invest?

The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines

WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.

Indrajit Bandyopadhyay headshot

Is ISRG's Procedure Growth Enough to Offset Margin Pressures in 2025?

Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $515.09, marking a +1.12% move from the previous day.

Zacks Equity Research

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Indrajit Bandyopadhyay headshot

ISRG vs BSX: Which Medical Device Stock Has More Room to Run?

Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $512.11, marking a -1.34% move from the previous day.

Indrajit Bandyopadhyay headshot

ISRG's Minimally Invasive Ecosystem Powers Surgical Precision

ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $522.41, marking a -1.36% move from the previous day.

Harshit Gupta headshot

ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong

Intuitive Surgical trims margin outlook on tariff headwinds, but strong procedure growth and financial resilience bolster its long-term case.

Zacks Equity Research

Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views?

The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Indrajit Bandyopadhyay headshot

Intuitive Surgical Stock Gains 12.7% QTD: Is it Still a Buy Now?

ISRG's shares seem to recover after declining more than 30% from its all-time high. Is it the right time to invest?

Indrajit Bandyopadhyay headshot

Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential

ISRG's da Vinci 5 is gaining momentum with key innovations like Force Feedback and strong Q1 placements boosting adoption.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $557.95, moving +1.11% from the previous trading session.

Zacks Equity Research

Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands

Zacks highlights strong showings from ABBV, ISRG, HBB and AXIL, while BRK.B gains on insurance growth and capital strength despite headwinds.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $555.75, marking a +0.6% move from the previous day.

Mark Vickery headshot

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.